Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy
Clinical trial NCT04276337 · UNKNOWN
Trial details
- NCT number
- NCT04276337
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-01
- Primary completion
- 2020-04-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.